Qiyu Li[Author] - Search Results

Year	Number of Results
2003	1
2004	3
2006	1
2008	1
2009	2
2010	3
2011	4
2012	4
2013	3
2014	3
2015	2
2016	1
2017	2
2018	2
2019	8
2020	5
2021	15
2022	20
2023	19
2024	9

1

The ZAR1 resistosome is a calcium-permeable channel triggering plant immune signaling.

Bi G, Su M, Li N, Liang Y, Dang S, Xu J, Hu M, Wang J, Zou M, Deng Y, Li Q, Huang S, Li J, Chai J, He K, Chen YH, Zhou JM. Bi G, et al. Among authors: li q. Cell. 2021 Jun 24;184(13):3528-3541.e12. doi: 10.1016/j.cell.2021.05.003. Epub 2021 May 12. Cell. 2021. PMID: 33984278 Free article.

2

Platelet-Like Fusogenic Liposome-Mediated Targeting Delivery of miR-21 Improves Myocardial Remodeling by Reprogramming Macrophages Post Myocardial Ischemia-Reperfusion Injury.

Tan H, Song Y, Chen J, Zhang N, Wang Q, Li Q, Gao J, Yang H, Dong Z, Weng X, Wang Z, Sun D, Yakufu W, Pang Z, Huang Z, Ge J. Tan H, et al. Among authors: li q. Adv Sci (Weinh). 2021 Aug;8(15):e2100787. doi: 10.1002/advs.202100787. Epub 2021 Jun 17. Adv Sci (Weinh). 2021. PMID: 34137511 Free PMC article.

3

Targeted immunomodulation therapy for cardiac repair by platelet membrane engineering extracellular vesicles via hitching peripheral monocytes.

Li Q, Huang Z, Wang Q, Gao J, Chen J, Tan H, Li S, Wang Z, Weng X, Yang H, Pang Z, Song Y, Qian J, Ge J. Li Q, et al. Biomaterials. 2022 May;284:121529. doi: 10.1016/j.biomaterials.2022.121529. Epub 2022 Apr 16. Biomaterials. 2022. PMID: 35447403

4

Protective effect of HINT2 on mitochondrial function via repressing MCU complex activation attenuates cardiac microvascular ischemia-reperfusion injury.

Li S, Chen J, Liu M, Chen Y, Wu Y, Li Q, Ma T, Gao J, Xia Y, Fan M, Chen A, Lu D, Su E, Xu F, Chen Z, Qian J, Ge J. Li S, et al. Among authors: li q. Basic Res Cardiol. 2021 Dec 16;116(1):65. doi: 10.1007/s00395-021-00905-4. Basic Res Cardiol. 2021. PMID: 34914018 Free PMC article.

5

Pertuzumab Plus Trastuzumab With or Without Chemotherapy Followed by Emtansine in ERBB2-Positive Metastatic Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.

Huober J, Weder P, Ribi K, Thürlimann B, Thery JC, Li Q, Vanlemmens L, Guiu S, Brain E, Grenier J, Dalenc F, Levy C, Savoye AM, Müller A, Membrez-Antonioli V, Gérard MA, Lemonnier J, Hawle H, Dietrich D, Boven E, Bonnefoi H; Swiss Group for Clinical Cancer Research, Unicancer Breast Group, and Dutch Breast Cancer Research Group. Huober J, et al. Among authors: li q. JAMA Oncol. 2023 Oct 1;9(10):1381-1389. doi: 10.1001/jamaoncol.2023.2909. JAMA Oncol. 2023. PMID: 37561451

6

LPS adsorption and inflammation alleviation by polymyxin B-modified liposomes for atherosclerosis treatment.

Liu H, Wang H, Li Q, Wang Y, He Y, Li X, Sun C, Ergonul O, Can F, Pang Z, Zhang B, Hu Y. Liu H, et al. Among authors: li q. Acta Pharm Sin B. 2023 Sep;13(9):3817-3833. doi: 10.1016/j.apsb.2023.06.005. Epub 2023 Jun 13. Acta Pharm Sin B. 2023. PMID: 37719368 Free PMC article.

7

L-carnitine alleviates cardiac microvascular dysfunction in diabetic cardiomyopathy by enhancing PINK1-Parkin-dependent mitophagy through the CPT1a-PHB2-PARL pathways.

Li S, Liu M, Chen J, Chen Y, Yin M, Zhou Y, Li Q, Xu F, Li Y, Yan X, Xia Y, Chen A, Lu D, Li C, Shen L, Chen Z, Qian J, Ge J. Li S, et al. Among authors: li q. Acta Physiol (Oxf). 2023 Jul;238(3):e13975. doi: 10.1111/apha.13975. Epub 2023 Apr 30. Acta Physiol (Oxf). 2023. PMID: 37042471

8

Advances in CLARITY-based tissue clearing and imaging.

Du H, Hou P, Zhang W, Li Q. Du H, et al. Among authors: li q. Exp Ther Med. 2018 Sep;16(3):1567-1576. doi: 10.3892/etm.2018.6374. Epub 2018 Jun 29. Exp Ther Med. 2018. PMID: 30186373 Free PMC article. Review.

9

Biomimetic Nano-Degrader Based CD47-SIRPα Immune Checkpoint Inhibition Promotes Macrophage Efferocytosis for Cardiac Repair.

Gao J, Pang Z, Wang Q, Tan Y, Li Q, Tan H, Chen J, Yakufu W, Wang Z, Yang H, Zhang J, Sun D, Weng X, Wang Q, Qian J, Song Y, Huang Z, Ge J. Gao J, et al. Among authors: li q. Adv Sci (Weinh). 2024 Mar 13:e2306388. doi: 10.1002/advs.202306388. Online ahead of print. Adv Sci (Weinh). 2024. PMID: 38477522

10

Targeted delivery and ROS-responsive release of Resolvin D1 by platelet chimeric liposome ameliorates myocardial ischemia-reperfusion injury.

Weng X, Tan H, Huang Z, Chen J, Zhang N, Wang Q, Li Q, Gao J, Sun D, Yakufu W, Wang Z, Li W, Zhu G, Pang Z, Song Y, Qian J, Ge J. Weng X, et al. Among authors: li q. J Nanobiotechnology. 2022 Oct 20;20(1):454. doi: 10.1186/s12951-022-01652-x. J Nanobiotechnology. 2022. PMID: 36266658 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

98 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

98 results

Results by year